Supplemental Financial Information (Tables)

12 Months Ended

Dec. 31, 2014

Supplemental Financial Information

Schedule of interest expense, net

years ended December 31 (in millions)	2014			2013			2012
Interest expense	$	429		$	299		$	104
Interest and dividend income		(38	)		(21	)		(20	)
Interest expense, net	$	391		$	278		$	84

Schedule of accounts payable and accrued liabilities

as of December 31 (in millions)	2014		2013
Sales rebates	$	1,384	$	1,401
Accounts payable		881		933
Due to Abbott Laboratories		536		876
Dividends payable		791		643
Salaries, wages and commissions		623		621
Royalty license arrangements		821		443
Other		1,918		1,531
Accounts payable and accrued liabilities	$	6,954	$	6,448

Schedule of long-term liabilities

as of December 31 (in millions)	2014		2013
Deferred income taxes	$	630	$	570
Pension and other post-employment benefits		2,220		1,628
Other		990		1,337
Long-term liabilities	$	3,840	$	3,535